Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 24125449)

1.

Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.

Bark CM, Gitta P, Ogwang S, Nsereko M, Thiel BA, Boom WH, Eisenach KD, Joloba ML, Johnson JL.

Int J Tuberc Lung Dis. 2013 Nov;17(11):1448-51. doi: 10.5588/ijtld.13.0063.

PMID:
24125449
2.
3.

Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.

Diacon AH, Maritz JS, Venter A, van Helden PD, Andries K, McNeeley DF, Donald PR.

Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1561-5. doi: 10.1007/s10096-010-1043-7. Epub 2010 Sep 4.

PMID:
20820832
4.

Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity.

Kayigire XA, Friedrich SO, Venter A, Dawson R, Gillespie SH, Boeree MJ, Heinrich N, Hoelscher M, Diacon AH; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics.

J Clin Microbiol. 2013 Jun;51(6):1894-8. doi: 10.1128/JCM.03290-12. Epub 2013 Apr 17.

5.

Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents.

Diacon AH, Maritz JS, Venter A, van Helden PD, Dawson R, Donald PR.

Clin Microbiol Infect. 2012 Jul;18(7):711-7. doi: 10.1111/j.1469-0691.2011.03626.x. Epub 2011 Aug 18.

6.

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.

Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, van Niekerk C, Everitt D, Winter H, Becker P, Mendel CM, Spigelman MK.

Lancet. 2012 Sep 15;380(9846):986-93. doi: 10.1016/S0140-6736(12)61080-0. Epub 2012 Jul 23.

PMID:
22828481
7.

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.

Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA.

Tuber Lung Dis. 1992 Feb;73(1):33-8.

PMID:
1326348
8.

The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment.

Sirgel FA, Botha FJ, Parkin DP, Van De Wal BW, Donald PR, Clark PK, Mitchison DA.

J Antimicrob Chemother. 1993 Dec;32(6):867-75.

PMID:
8144427
9.

Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.

Pheiffer C, Carroll NM, Beyers N, Donald P, Duncan K, Uys P, van Helden P.

Int J Tuberc Lung Dis. 2008 Jul;12(7):792-8.

PMID:
18544206
10.

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.

Diacon AH, Dawson R, Hanekom M, Narunsky K, Venter A, Hittel N, Geiter LJ, Wells CD, Paccaly AJ, Donald PR.

Int J Tuberc Lung Dis. 2011 Jul;15(7):949-54. doi: 10.5588/ijtld.10.0616.

PMID:
21682970
11.

Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.

Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, RĂ¼sch-Gerdes S.

East Afr Med J. 1999 Jun;76(6):307-13.

PMID:
10750516
12.

Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.

Hafner R, Cohn JA, Wright DJ, Dunlap NE, Egorin MJ, Enama ME, Muth K, Peloquin CA, Mor N, Heifets LB.

Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):918-23.

PMID:
9310014
13.

The early bactericidal activity of amikacin in pulmonary tuberculosis.

Donald PR, Sirgel FA, Venter A, Smit E, Parkin DP, Van de Wal BW, Mitchison DA.

Int J Tuberc Lung Dis. 2001 Jun;5(6):533-8.

PMID:
11409580
14.

Phase II dose-ranging trial of the early bactericidal activity of PA-824.

Diacon AH, Dawson R, du Bois J, Narunsky K, Venter A, Donald PR, van Niekerk C, Erondu N, Ginsberg AM, Becker P, Spigelman MK.

Antimicrob Agents Chemother. 2012 Jun;56(6):3027-31. doi: 10.1128/AAC.06125-11. Epub 2012 Mar 19.

15.

The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.

Donald PR, Sirgel FA, Botha FJ, Seifart HI, Parkin DP, Vandenplas ML, Van de Wal BW, Maritz JS, Mitchison DA.

Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):895-900.

PMID:
9310010
16.

Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.

Li L, Mahan CS, Palaci M, Horter L, Loeffelholz L, Johnson JL, Dietze R, Debanne SM, Joloba ML, Okwera A, Boom WH, Eisenach KD.

J Clin Microbiol. 2010 Jan;48(1):46-51. doi: 10.1128/JCM.01526-09. Epub 2009 Nov 18.

17.

The early bactericidal activity of anti-tuberculosis drugs: a literature review.

Donald PR, Diacon AH.

Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S75-83. doi: 10.1016/S1472-9792(08)70038-6. Review.

PMID:
18762155
18.

Early bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide in pulmonary tuberculosis patients.

Paramasivan CN, Herbert D, Umapathy KC, Rahman F, Krishnamurthy PV, Prabhakar R.

Indian J Med Res. 1994 Jul;100:1-4.

PMID:
7927544
19.

The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.

Sirgel FA, Botha FJ, Parkin DP, Van de Wal BW, Schall R, Donald PR, Mitchison DA.

Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):901-5.

PMID:
9310011
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk